- New
Mounjaro 2.5mg (tirzepatide)
£359.90
Tax included
Mounjaro 2.5 mg is the starting dose of tirzepatide, prescribed for adults with type 2 diabetes to improve blood sugar control. It is also being studied for weight management benefits.
Mounjaro (tirzepatide) 2.5 mg is an injectable prescription medicine used to treat type 2 diabetes in adults. It activates both GLP-1 and GIP receptors, helping the body release insulin, lower glucose production, and slow digestion. The 2.5 mg dose is typically the initial step in treatment, allowing the body to adjust before moving to higher doses. Used alongside diet and exercise, Mounjaro helps lower HbA1c levels and supports long-term blood sugar management.
Comments (0)
No customer reviews for the moment.
14 other products in the same category:
Mounjaro 2.5 mg is the starting dose of tirzepatide, prescribed for adults with type 2 diabetes to improve blood sugar control. It is also being studied for weight management benefits.